Evidence map›Paper›PMID 27623074›Full record

ArticleOncotarget2017

inFRank: a ranking-based identification of influential genes in biological networks.

Xiuliang Cui, Xiaofeng Li, Jing Li, Xue Wang, Wen Sun, Zhuo Cheng, Jin Ding, Hongyang Wang

Abstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. CompositeView: A Network-Based Visualization Tool.Big data and cognitive computing · 2022
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiuliang CuiThe International Cooperation Laboratory on Signal Transduction, Shanghai, 200433, China.
Xiaofeng LiNational Center for Liver Cancer, Eastern Hepatobiliary Surgery Institute, Shanghai, 200433, China.
Jing LiDepartment of Surgery, The Second Military Medical University, Shanghai, 200433, China.
Xue WangThe International Cooperation Laboratory on Signal Transduction, Shanghai, 200433, China.
Wen SunThe International Cooperation Laboratory on Signal Transduction, Shanghai, 200433, China.
Zhuo ChengThe International Cooperation Laboratory on Signal Transduction, Shanghai, 200433, China.
Jin DingThe International Cooperation Laboratory on Signal Transduction, Shanghai, 200433, China.
Hongyang WangThe International Cooperation Laboratory on Signal Transduction, Shanghai, 200433, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Capturing the predominant driver genes is critical in the analysis of high-throughput experimental data; however, existing methods scarcely include the unique characters of biological networks. Herein we introduced a ranking-based computational framework (inFRank) to rank the proteins by their influence. Using inFRank, we identified the top 20 influential genes in hepatocellular carcinoma (HCC). Network analysis revealed a prominent community composed of 7 influential genes. Intriguingly, five genes among the community were critical for mitotic spindle assembly checkpoint (SAC), suggesting that dysregulation of SAC could be a distinct feature of HCC and targeting SAC-associated genes might be a promising therapeutic strategy. Cox regression analysis revealed that CDC20 exerted as an independent risk factor for patient survival, indicating that CDC20 could be a novel biomarker for HCC prognosis. inFRank was then used for pan-cancer study, and all of the most influential genes in 18 cancers were achieved. We identified altogether 19 genes that were important in multiple cancers, and observed that cancers originating from the same organ or function-related organs tended to share more influential genes. Collectively, our results demonstrated that the inFRank was a powerful approach for deep interpretation of high-throughput data and better understanding of complex diseases.

Indexed as

Gene Regulatory NetworksAdultAgedBiomarkers, TumorCarcinoma, HepatocellularComputational BiologyFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGenetic Association StudiesGenetic Predisposition to DiseaseHumansLiver NeoplasmsMaleMiddle AgedPrognosisBiomarkers, Tumorinfluential rankliver hepatocellular carcinomanetwork analysisprognosisTCGA

Identifiers

PMID27623074
PMCPMC5546442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.